{"id":55377,"date":"2022-01-15T09:57:38","date_gmt":"2022-01-15T08:57:38","guid":{"rendered":"https:\/\/nationalwire.com.ng\/?p=55377"},"modified":"2022-01-15T09:57:38","modified_gmt":"2022-01-15T08:57:38","slug":"fmdq-admits-mecure-industries-commercial-papers","status":"publish","type":"post","link":"https:\/\/nationalwire.com.ng\/sub\/fmdq-admits-mecure-industries-commercial-papers\/","title":{"rendered":"FMDQ Admits MeCure Industries Commercial Papers"},"content":{"rendered":"<p>&nbsp;<\/p>\n<p>FMDQ Securities Exchange has approved the quotation of the MeCure Industries Ltd Series 1 and Series 2 Commercial Papers (CPs) on its platform.<\/p>\n<p>In a statement issued on Friday, FMDQ explained that the Series 1 (N0.49 billion) and Series 2 (N1.44 billion) were under the company\u2019s N20 billion CP issuance programme on the FMDQ platform.<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-55379\" src=\"https:\/\/nationalwire.com.ng\/wp-content\/uploads\/2022\/01\/fmdq-otc-web-design-showcase-1-300x175.jpg\" alt=\"\" width=\"300\" height=\"175\" \/><\/p>\n<p>Commenting on the quotation, Mr Samir Udani, the Chairman\/Chief Executive Officer, MeCure Industries Ltd., said the issuance would help the company meet its short-term working capital and funding requirements.<\/p>\n<p>Udani added that it would strengthen the company\u2019s commitment to building and shaping positively, the healthcare industry in Nigeria.<\/p>\n<p>Also speaking on the transaction, the sponsor of the CP and a Registration Member (Quotations) of the Exchange, Mr Femi Ademola, Executive Director, Cordros Capital Ltd, said the company was proud to sponsor the CP.<\/p><div data-ad-id=\"32665\" style=\"text-align:center; margin-top:0px; margin-bottom:0px; margin-left:0px; margin-right:0px;float:none;\" class=\"afw afw_ad_image afw_ad afwadid-32665  \">\r\n                                                            <div style=\"font-size:10px;text-align:center;color:#cccccc;\">Advertisement<\/div>\r\n\t\t\t\t\t\t\t<a target=\"_blank\" href=\"http:\/\/www.accessbankplc.com\" rel=\"nofollow\"><img decoding=\"async\" height=\"auto\" max-width=\"100%\" src=\"https:\/\/nationalwire.com.ng\/wp-content\/uploads\/2019\/06\/Banner-1.jpg\"><\/a>\r\n                                                                        \r\n\t\t\t\t\t\t\t<\/div>\n<p>\u201cCordros Capital is proud to have sponsored the quotation of the MeCure Industries Ltd., N0.49 billion Series 1 and N1.44 billion Series 2 CPs, under the N20 billion CP programme.<\/p>\n<p>\u201cThis transaction has provided an alternative source of funding to the issuer and will assist in bolstering its working capital. Hence, positioning it as a leader in the pharmaceutical industry,\u201d Ademola said.<\/p>\n<p>MeCure Industries is a leading human therapeutics company in the pharmaceutical industry in Nigeria.<\/p>\n<p>The company pioneered the development of novel products and launched the pharmaceutical industry\u2019s first tablet in a capsule formulation called \u2018Liquitab Floatcap\u2019.<\/p>\n<p>FMDQ Group is Africa\u2019s first vertically integrated financial market infrastructure group, strategically positioned to provide registration, listing, quotation and noting services; integrated trading, clearing &amp; central counterparty, settlement, and risk among others. nan.<\/p>\n<!-- AddThis Advanced Settings generic via filter on the_content --><!-- AddThis Share Buttons generic via filter on the_content -->","protected":false},"excerpt":{"rendered":"<p>FMDQ Securities Exchange has approved the quotation of the MeCure Industries Ltd Series 1 and Series 2 Commercial Papers (CPs) on its platform.<!-- AddThis Advanced Settings generic via filter on get_the_excerpt --><!-- AddThis Share Buttons generic via filter on get_the_excerpt --><\/p>\n","protected":false},"author":6,"featured_media":36307,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_exactmetrics_skip_tracking":false,"_exactmetrics_sitenote_active":false,"_exactmetrics_sitenote_note":"","_exactmetrics_sitenote_category":0,"footnotes":""},"categories":[23,17],"tags":[1189],"coauthors":[2391],"class_list":["post-55377","post","type-post","status-publish","format-standard","has-post-thumbnail","","category-business","category-news","tag-fmdq"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v18.9 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>FMDQ Admits MeCure Industries Commercial Papers - National Wire<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/nationalwire.com.ng\/sub\/fmdq-admits-mecure-industries-commercial-papers\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"FMDQ Admits MeCure Industries Commercial Papers - National Wire\" \/>\n<meta property=\"og:description\" content=\"FMDQ Securities Exchange has approved the quotation of the MeCure Industries Ltd Series 1 and Series 2 Commercial Papers (CPs) on its platform.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/nationalwire.com.ng\/sub\/fmdq-admits-mecure-industries-commercial-papers\/\" \/>\n<meta property=\"og:site_name\" content=\"National Wire\" \/>\n<meta property=\"article:published_time\" content=\"2022-01-15T08:57:38+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/nationalwire.com.ng\/sub\/wp-content\/uploads\/2019\/11\/FMDQ-EXCHANGE.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1010\" \/>\n\t<meta property=\"og:image:height\" content=\"246\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Friday Ekeoba\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebSite\",\"@id\":\"https:\/\/nationalwire.com.ng\/sub\/#website\",\"url\":\"https:\/\/nationalwire.com.ng\/sub\/\",\"name\":\"National Wire\",\"description\":\"About Nigerians, Nigerian Business and Other Stories\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/nationalwire.com.ng\/sub\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/nationalwire.com.ng\/sub\/fmdq-admits-mecure-industries-commercial-papers\/#primaryimage\",\"url\":\"https:\/\/nationalwire.com.ng\/sub\/wp-content\/uploads\/2019\/11\/FMDQ-EXCHANGE.png\",\"contentUrl\":\"https:\/\/nationalwire.com.ng\/sub\/wp-content\/uploads\/2019\/11\/FMDQ-EXCHANGE.png\",\"width\":1010,\"height\":246},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/nationalwire.com.ng\/sub\/fmdq-admits-mecure-industries-commercial-papers\/#webpage\",\"url\":\"https:\/\/nationalwire.com.ng\/sub\/fmdq-admits-mecure-industries-commercial-papers\/\",\"name\":\"FMDQ Admits MeCure Industries Commercial Papers - National Wire\",\"isPartOf\":{\"@id\":\"https:\/\/nationalwire.com.ng\/sub\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/nationalwire.com.ng\/sub\/fmdq-admits-mecure-industries-commercial-papers\/#primaryimage\"},\"datePublished\":\"2022-01-15T08:57:38+00:00\",\"dateModified\":\"2022-01-15T08:57:38+00:00\",\"author\":{\"@id\":\"https:\/\/nationalwire.com.ng\/sub\/#\/schema\/person\/e2ab303e561d755b325fc9cea3854927\"},\"breadcrumb\":{\"@id\":\"https:\/\/nationalwire.com.ng\/sub\/fmdq-admits-mecure-industries-commercial-papers\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/nationalwire.com.ng\/sub\/fmdq-admits-mecure-industries-commercial-papers\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/nationalwire.com.ng\/sub\/fmdq-admits-mecure-industries-commercial-papers\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/nationalwire.com.ng\/sub\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"FMDQ Admits MeCure Industries Commercial Papers\"}]},{\"@type\":\"Person\",\"@id\":\"https:\/\/nationalwire.com.ng\/sub\/#\/schema\/person\/e2ab303e561d755b325fc9cea3854927\",\"name\":\"Friday Ekeoba\",\"url\":\"https:\/\/nationalwire.com.ng\/sub\/author\/friday\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"FMDQ Admits MeCure Industries Commercial Papers - National Wire","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/nationalwire.com.ng\/sub\/fmdq-admits-mecure-industries-commercial-papers\/","og_locale":"en_US","og_type":"article","og_title":"FMDQ Admits MeCure Industries Commercial Papers - National Wire","og_description":"FMDQ Securities Exchange has approved the quotation of the MeCure Industries Ltd Series 1 and Series 2 Commercial Papers (CPs) on its platform.","og_url":"https:\/\/nationalwire.com.ng\/sub\/fmdq-admits-mecure-industries-commercial-papers\/","og_site_name":"National Wire","article_published_time":"2022-01-15T08:57:38+00:00","og_image":[{"width":1010,"height":246,"url":"https:\/\/nationalwire.com.ng\/sub\/wp-content\/uploads\/2019\/11\/FMDQ-EXCHANGE.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_misc":{"Written by":"Friday Ekeoba","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebSite","@id":"https:\/\/nationalwire.com.ng\/sub\/#website","url":"https:\/\/nationalwire.com.ng\/sub\/","name":"National Wire","description":"About Nigerians, Nigerian Business and Other Stories","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/nationalwire.com.ng\/sub\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/nationalwire.com.ng\/sub\/fmdq-admits-mecure-industries-commercial-papers\/#primaryimage","url":"https:\/\/nationalwire.com.ng\/sub\/wp-content\/uploads\/2019\/11\/FMDQ-EXCHANGE.png","contentUrl":"https:\/\/nationalwire.com.ng\/sub\/wp-content\/uploads\/2019\/11\/FMDQ-EXCHANGE.png","width":1010,"height":246},{"@type":"WebPage","@id":"https:\/\/nationalwire.com.ng\/sub\/fmdq-admits-mecure-industries-commercial-papers\/#webpage","url":"https:\/\/nationalwire.com.ng\/sub\/fmdq-admits-mecure-industries-commercial-papers\/","name":"FMDQ Admits MeCure Industries Commercial Papers - National Wire","isPartOf":{"@id":"https:\/\/nationalwire.com.ng\/sub\/#website"},"primaryImageOfPage":{"@id":"https:\/\/nationalwire.com.ng\/sub\/fmdq-admits-mecure-industries-commercial-papers\/#primaryimage"},"datePublished":"2022-01-15T08:57:38+00:00","dateModified":"2022-01-15T08:57:38+00:00","author":{"@id":"https:\/\/nationalwire.com.ng\/sub\/#\/schema\/person\/e2ab303e561d755b325fc9cea3854927"},"breadcrumb":{"@id":"https:\/\/nationalwire.com.ng\/sub\/fmdq-admits-mecure-industries-commercial-papers\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/nationalwire.com.ng\/sub\/fmdq-admits-mecure-industries-commercial-papers\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/nationalwire.com.ng\/sub\/fmdq-admits-mecure-industries-commercial-papers\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/nationalwire.com.ng\/sub\/"},{"@type":"ListItem","position":2,"name":"FMDQ Admits MeCure Industries Commercial Papers"}]},{"@type":"Person","@id":"https:\/\/nationalwire.com.ng\/sub\/#\/schema\/person\/e2ab303e561d755b325fc9cea3854927","name":"Friday Ekeoba","url":"https:\/\/nationalwire.com.ng\/sub\/author\/friday\/"}]}},"_links":{"self":[{"href":"https:\/\/nationalwire.com.ng\/sub\/wp-json\/wp\/v2\/posts\/55377","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nationalwire.com.ng\/sub\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nationalwire.com.ng\/sub\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nationalwire.com.ng\/sub\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/nationalwire.com.ng\/sub\/wp-json\/wp\/v2\/comments?post=55377"}],"version-history":[{"count":1,"href":"https:\/\/nationalwire.com.ng\/sub\/wp-json\/wp\/v2\/posts\/55377\/revisions"}],"predecessor-version":[{"id":55380,"href":"https:\/\/nationalwire.com.ng\/sub\/wp-json\/wp\/v2\/posts\/55377\/revisions\/55380"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nationalwire.com.ng\/sub\/wp-json\/wp\/v2\/media\/36307"}],"wp:attachment":[{"href":"https:\/\/nationalwire.com.ng\/sub\/wp-json\/wp\/v2\/media?parent=55377"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nationalwire.com.ng\/sub\/wp-json\/wp\/v2\/categories?post=55377"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nationalwire.com.ng\/sub\/wp-json\/wp\/v2\/tags?post=55377"},{"taxonomy":"author","embeddable":true,"href":"https:\/\/nationalwire.com.ng\/sub\/wp-json\/wp\/v2\/coauthors?post=55377"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}